A computational rule-based model of MAPK/ERK system regulation

The MAPK/ERK pathway coordinates multiple cellular functions, including proliferation, apoptosis, and motility, yet it is frequently modeled as a one-purpose cascade. Pathway complexity stems from the existence of isoforms that are regulated differently and have specific interacting partners. Here, we overcome combinatorial complexity by constructing a rule-based model of the MAPK/ERK pathway that accounts for differential regulation of MEK and RAF isoforms and RAF interactions with 14-3-3 proteins. The model addresses signaling based on the enzymatic cascade as well as regulatory protein-protein interactions. We propose that at low concentrations of growth factors, RAS is activated only in a portion of the membrane. This allows the model to reconcile the observed graded and switch-like responses observed at the upper (RAS and RAF) and the lowest (ERK) tiers of the pathway, respectively. We demonstrate that functional differences between BRAF and CRAF, or ARAF, can arise from their distinct interactions with 14-3-3. The 14-3-3 dimers inhibit all RAF monomers in the closed form and preferentially stabilize BRAF-CRAF or BRAF-ARAF dimers and may not stabilize RAF dimers without BRAF. The constructed model is used to explore qualitative differences in MAPK/ERK pathway signaling across different cell lines. The exploration starts from the nominal model parameters chosen to reflect a generic cell.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-03-21
DOI
https://doi.org/10.1038/s41598-026-44353-3
Primary Topic
14-3-3 protein interactions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A computational rule-based model of MAPK/ERK system regulation

Paweł Kocieniewski, Tomasz Lipniacki
Scientific Reports
14-3-3 protein interactions
article

A computational rule-based model of MAPK/ERK system regulation

Paweł Kocieniewski, Tomasz Lipniacki
article en

Abstract

The MAPK/ERK pathway coordinates multiple cellular functions, including proliferation, apoptosis, and motility, yet it is frequently modeled as a one-purpose cascade. Pathway complexity stems from the existence of isoforms that are regulated differently and have specific interacting partners. Here, we overcome combinatorial complexity by constructing a rule-based model of the MAPK/ERK pathway that accounts for differential regulation of MEK and RAF isoforms and RAF interactions with 14-3-3 proteins. The model addresses signaling based on the enzymatic cascade as well as regulatory protein-protein interactions. We propose that at low concentrations of growth factors, RAS is activated only in a portion of the membrane. This allows the model to reconcile the observed graded and switch-like responses observed at the upper (RAS and RAF) and the lowest (ERK) tiers of the pathway, respectively. We demonstrate that functional differences between BRAF and CRAF, or ARAF, can arise from their distinct interactions with 14-3-3. The 14-3-3 dimers inhibit all RAF monomers in the closed form and preferentially stabilize BRAF-CRAF or BRAF-ARAF dimers and may not stabilize RAF dimers without BRAF. The constructed model is used to explore qualitative differences in MAPK/ERK pathway signaling across different cell lines. The exploration starts from the nominal model parameters chosen to reflect a generic cell.

Scientific Reports
Institute of Fundamental Technological Research (PL)
Openalex Percentile: Top 14%
14-3-3 protein interactions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.